The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSareum Share News (SAR)

Share Price Information for Sareum (SAR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 35.00
Bid: 34.00
Ask: 36.00
Change: 1.50 (4.48%)
Spread: 2.00 (5.882%)
Open: 33.50
High: 36.00
Low: 33.00
Prev. Close: 33.50
SAR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Small caps round-up: YouGov, Sareum and InterQuest...

Tue, 07th Aug 2012 11:25

Environmental Recycling Technologies, which owns the rights to the Powder Impression Moulding (PIM) process which is capable of converting mixed waste plastics into commercially viable products, has confirmed that its US parent application, entitled 'Process for Forming Plastic, Apparatuses for Forming Plastic and Articles Made Therefrom', has been granted by the US Patent Office. This is ERT's core patent in the US for the PIM process. Sareum, a specialist cancer drug discovery business, has said it notes the recent significant rise in its share price and has confirmed that "advanced stages of negotiations are taking place with a potential licencing partner". It added these "may or may not lead to a licencing agreement regarding one of the company's research programmes". Shares were up 184% on Tuesday, equal to 1.15p. The stock has gained 42% over the past year, and 163% in the past month. YouGov, the online market research firm, is anticipating that its operating profit will be in line with expectations with second half revenue similar to that achieved in the first half, reflecting the firm's focus on profitability in the German business and the expected end to a long-term contract in Iraq. The firm said its balance sheet remains strong with cash at July 31st of around £7.0m. TClarke, a building services company, reported a decline in pre-tax profit for the half year at £0.5m (2011: £1.4m) on revenues of £90.7m (2011: £92.6m), with the profit margin also lower at 0.5% compared to 1.5% the previous year. Basic earnings per share dropped from 2.38p to 0.79p, while net cash climbed £0.1m to £0.7m. The interim dividend was maintained at 1p per share. The firm blamed a lack of confidence across the sector for the declines and said that with a number of projects due to begin shortly it is confident of significant revenue progress in the second half. Shares in InterQuest Group, a specialist information technology recruitment group, took a hit after it admitted earnings before interest, tax, depreciation and amortisation are expected to be down year-on-year, in the region of £1.15m (2011: £1.86m), and warned the impact of investments and restructuring on profitability for 2012 will be around £1.6m. Trading conditions were poor in both the UK and Far East, particularly in the second quarter and particularly in the banking and finance sectors from which it derives 27% of its net fee income. This has meant profitability from investments has taken longer than anticipated. NR
More News
10 Mar 2016 13:00

Sareum Holdings Unaware Of Reason For Share Price Jump

Read more
24 Feb 2016 12:25

Sareum inches closer to drug breakthrough

(ShareCast News) - Sareum Holdings was still running on the smell of an oily rag in its interim report on Wednesday, but the company was confident it was heading towards a breakthrough in its durgs under development. The AIM-traded cancer drug discovery and development business saw no revenue during

Read more
24 Feb 2016 09:40

Sareum Holdings Reports Narrowed Loss As It Focuses On CHK1 Trials

Read more
1 Feb 2016 09:14

Sareum Submits Clinical Trial Applications For Cancer Drug Candidate

Read more
15 Dec 2015 08:40

Sareum Clinical Trials Application For Cancer Drug Coming In January

Read more
8 Dec 2015 15:58

AGM, EGM Calendar - Week Ahead

Read more
26 Oct 2015 08:59

Sareum Holdings Loss Widens As It Moves Towards Clinical Trials

Read more
15 Sep 2015 08:06

Sareum Holdings Gets US, European Patents For Aurora+FLT3 Inhibitors

Read more
23 Jul 2015 09:06

Sareum Says Journal Reports On Lung And Pancreatic Cancer Treatment

Read more
17 Jun 2015 07:56

Sareum Wins Funding To Investigate Treatment Of Adolescent Leukaemia

Read more
28 May 2015 11:26

LONDON MIDDAY BRIEFING: Corporate Sponsors Join Backlash Against FIFA

Read more
28 May 2015 10:35

WINNERS & LOSERS: Sports Direct Expects Earnings To Beat Forecasts

Read more
28 May 2015 07:13

Sareum Raises GBP1.4 Million Via Discounted Share Placing (ALLISS)

Read more
12 May 2015 12:28

LONDON MIDDAY BRIEFING: EasyJet Outlook Hits Turbulence

Read more
12 May 2015 10:36

WINNERS & LOSERS: easyJet Slides As Analysts Set To Cut Forecasts

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.